Miclara LQ by is a Otc medication manufactured, distributed, or labeled by Key Therapeutics, TG United. Drug facts, warnings, and ingredients follow.
Miclara LQ- doxylamine succinate, pseudoephedrine hydrochloride liquid
Key Therapeutics
Disclaimer: Most OTC drugs are not reviewed and approved by FDA; however, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Do not exceed recommended dosage.
Do not use this product if you have
Do not exceed recommended dosage.
Adults and children
12 years of age and older:
Children 6 to under 12 years of age:
2 teaspoonfuls (10 mL) every 4 to 6 hours, not to exceed
8 teaspoonfuls (40mL) in 24-hour
period or as directed by a doctor.
1 teaspoonful (5 mL) every 4 to 6 hours, not to exceed 4 teaspoonfuls (20mL) in a 24-hour period or as directed by a doctor.
Children under 6 years of age: Consult a doctor
MICLARA LQ
triprolidine hydrochloride liquid |
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
||||||||||||||||||||||
|
Labeler - Key Therapeutics (080318791) |